Viewing Study NCT04413227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT04413227
Status: UNKNOWN
Last Update Posted: 2020-06-02
First Post: 2020-05-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module